Related Experiment Video
Updated: May 28, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
What Is the Current State of Stem Cell Therapy in Diabetes?
Estera Bakinowska1, Wojciech Jerzy Biniek1, Kajetan Kiełbowski1
1Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Abstract:
Diabetes mellitus is a chronic and progressive metabolic disorder associated with abnormal blood glucose levels. The term involves several diseases with different pathophysiology mechanisms and treatment strategies. Stem cell-based treatments represent an emerging strategy for patients with diabetes mellitus with severe pancreatic insufficiency and poor glycemic control. Over the last 20 years, researchers have investigated mesenchymal stem cell infusion and the transplantation of stem cell-derived β cells and islet tissues. This review aims to comprehensively discuss the latest advances in the field of stem cell use in diabetes, including clinical studies and preclinical experiments aiming at improving the efficacy and safety of stem cell use.
Insights
Stem cell therapies show promise for managing diabetes mellitus, particularly for those with severe pancreatic issues. Research focuses on mesenchymal stem cells and stem cell-derived tissues to improve treatment efficacy and safety.
Area of Science:
- Endocrinology and Metabolic Diseases
- Regenerative Medicine
- Cell Biology
Background:
- Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
- It encompasses various conditions with distinct pathophysiologies and treatment needs.
- Current treatments aim to manage blood glucose but often fall short for severe cases.
Purpose of the Study:
- To review recent advancements in stem cell applications for diabetes mellitus.
- To discuss both preclinical and clinical research in this field.
- To evaluate strategies for enhancing the safety and efficacy of stem cell therapies.
Main Methods:
- Review of scientific literature over the past 20 years.
- Analysis of studies involving mesenchymal stem cell infusion.
- Examination of research on transplantation of stem cell-derived beta cells and islet tissues.
Main Results:
- Stem cell-based treatments are an emerging option for patients with severe pancreatic insufficiency.
- Significant research has explored mesenchymal stem cells and stem cell-derived tissues.
- Ongoing studies aim to optimize efficacy and safety profiles.
Conclusions:
- Stem cell therapy represents a promising frontier for managing diabetes mellitus.
- Further research is crucial to refine stem cell-based approaches for clinical application.
- Improving safety and efficacy remains a key objective in stem cell research for diabetes.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Tissue Renewal without Stem Cells
However, failure of such a system...
